Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 days ago

Arcturus Therapeutics Holdings Inc.: Amova Asset Management Americas, Inc. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Amova Asset Management Americas, Inc. filed an amended Schedule 13G with the SEC (accession 0001140361-26-043682) updating its ownership position in Arcturus Therapeutics Holdings Inc. The amendment, disclosed in a regulatory filing, revises the asset manager's previously reported stake in the clinical-stage mRNA medicines developer. Schedule 13G filings are required of investors holding passive stakes above 5% of a company's shares, so the update signals a change in Amova's beneficial ownership. The filing did not disclose the size or direction of the stake change in the headline notice. Investors will watch for the full filing details to gauge whether the adjustment reflects a meaningful shift in institutional support for Arcturus.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Amova Asset Management Americas, Inc., Arcturus Therapeutics Holdings Inc.